'McKesson and CD&R near $5B-plus deal to buy infusion services provider'- Financial Times

McKesson Corporation is nearing a deal valued at over $5 billion to acquire an infusion services provider in partnership with Clayton, Dubilier & Rice (CD&R). This strategic move is aimed at expanding McKesson's capabilities in the healthcare services sector. The acquisition is expected to enhance McKesson's service offerings and strengthen its market position.